Burrill on Biotech - BioPharm International

ADVERTISEMENT

Burrill on Biotech

Moving the Needle on Healthcare

July 1, 2014

Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.

Eli Lilly's Cyramza Receives FDA Approval for Treatment of Advanced Gastric Cancer

April 22, 2014

Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.

Biotech IPOs on a Hot Streak

April 1, 2014

Life-sciences companies continue upward momentum in 2014.

Life-Sciences IPOs Take a Breather

January 1, 2014

Frenzy cools as investors seeking a quick return turn elsewhere.

Robust IPO Market for Life Sciences Sparks Change Among Investors

October 1, 2013

Early-stage companies are now embraced by buyers of new issues.

IPO Market Heats Up for Life-Sciences Companies

July 1, 2013

Biotech companies raise most money in 13 years.

Financing Innovation

April 1, 2013

Early-stage companies are finding alternatives to venture capital.

Accelerating Change Marks 2012 for Life Sciences

January 1, 2013

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Recent Therapeutics IPOs Outshine Market, but Performance Mixed for Broader Life-Sciences Issues

October 1, 2012

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

ADVERTISEMENT

ADVERTISEMENT

Click here